News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SCHAFER CAROL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/02/2023 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 49,000 options to buy
@ $9.55, valued at
$468k
|
|
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 3,620 shares
@ $4.02, valued at
$14.6k
|
|
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Bought 8,000 shares
@ $20, valued at
$160k
|
|
| 06/18/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/19/2020 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 11,500 options to buy
@ $1.97, valued at
$22.7k
|
|
| 05/15/2020 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 05/14/2020 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 8,097 shares
@ $0 |
|
| 04/03/2020 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 10,633 shares
@ $1.28, valued at
$13.6k
|
|
| 04/02/2020 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 1,605 shares
@ $0 |
|
| 04/02/2020 |
3
| SCHAFER CAROL (Director) has filed a Form 3 on INSMED Inc |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2019 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 1,250 options to buy
@ $6.09, valued at
$7.6k
|
|
| 06/06/2019 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 11,500 options to buy
@ $2.57, valued at
$29.6k
|
|
| 05/16/2019 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $9.17, valued at
$229.3k
|
|
| 05/16/2019 |
3
| SCHAFER CAROL (Director) has filed a Form 3 on FIVE PRIME THERAPEUTICS INC |
| 04/02/2019 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 5,166 shares
@ $2.59, valued at
$13.4k
|
|
| 12/20/2018 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Bought 5,000 shares
@ $3.3342, valued at
$16.7k
Granted 23,000 options to buy
@ $3.12, valued at
$71.8k
|
|
| 12/20/2018 |
3
| SCHAFER CAROL (Director) has filed a Form 3 on IDERA PHARMACEUTICALS, INC. |
|
|